Not applicableNot Yet RecruitingNCT07379489What this trial is testingAdjuvant Anti-PD-1 Therapy in Resected Hepatocellular CarcinomaWho this might be right forHCCAdjuvant TherapyRecurrence+1 more Tongji Hospital 300
Large-scale testing (Phase 3)WithdrawnNCT04465734What this trial is testingA Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCCWho this might be right forHepatocellular Carcinoma (HCC) Shanghai Henlius Biotech
Large-scale testing (Phase 3)UnknownNCT05737563What this trial is testingPD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Abdominal Stage 0 Sun Yat-sen University 380
Testing effectiveness (Phase 2)UnknownNCT04620837What this trial is testingTislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line ChemotherapyWho this might be right forSmall Cell Lung Carcinoma Chinese Academy of Medical Sciences 25
Testing effectiveness (Phase 2)UnknownNCT05919095What this trial is testingA Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder CancerWho this might be right forUnresectable Gallbladder Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05975307What this trial is testingTreating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and ChemoradiationWho this might be right forMuscle-Invasive Bladder CarcinomaProgrammed Cell Death Protein 1 InhibitorRadiotherapy Sun Yat-sen University 71
Large-scale testing (Phase 3)Study completedNCT02504372What this trial is testingStudy of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)Who this might be right forNon-small Cell Lung Cancer Merck Sharp & Dohme LLC 1,177
Large-scale testing (Phase 3)Study completedNCT03358875What this trial is testingComparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer BeiGene 805
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07615881What this trial is testingComparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With MelanomaWho this might be right forMelanoma (Skin Cancer) Amsterdam UMC, location VUmc 18
Testing effectiveness (Phase 2)Study completedNCT03190811What this trial is testingAnti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid TumorsWho this might be right forNeoplasms Capital Medical University 100
Early research (Phase 1)Ended earlyNCT06580938What this trial is testingLearn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerWho this might be right forNon Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more Pfizer 4
Testing effectiveness (Phase 2)Looking for participantsNCT03926338What this trial is testingNeoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal CancerWho this might be right forColorectal CancerMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)+1 more Sun Yat-sen University 270
Testing effectiveness (Phase 2)UnknownNCT04447326What this trial is testingToripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma First Affiliated Hospital of Guangxi Medical University 106
Testing effectiveness (Phase 2)Study completedNCT04669899What this trial is testingStudy of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid TumorsWho this might be right forCancer Jounce Therapeutics, Inc. 190
Not applicableUnknownNCT04886193What this trial is testingFLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal MetastasisWho this might be right forChemotherapyGastric Cancer Guangdong Provincial Hospital of Traditional Chinese Medicine 20
Not applicableUnknownNCT06335147What this trial is testingPD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon CancerWho this might be right forMetastatic Colon Cancer Henan Cancer Hospital 23
Very early researchWithdrawnNCT04223648What this trial is testingProgrammed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic MelanomaWho this might be right forMalignant Melanoma Yale University
Testing effectiveness (Phase 2)Looking for participantsNCT06782932What this trial is testingComparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Looking for participantsNCT07125547What this trial is testingNeoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral CancerWho this might be right forUreteral CancerNeoadjuvant TherapyPD-1 Inhibitor+3 more Tianjin Medical University Second Hospital 35
Early research (Phase 1)UnknownNCT06404281What this trial is testingΓδ T-PD-1 Ab Cells in the Treatment of Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Changzhou No.2 People's Hospital 9